XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2023
Mar. 31, 2022
OPERATING ACTIVITIES    
Net income (loss) $ 85,626 $ 107,356
Adjustments to reconcile to cash from operations:    
Depreciation 91,710 87,984
Amortization 9,476 9,751
Stock-based compensation expense 18,765 18,024
Restructuring and other charges, net (2,499) (2,444)
Gain on divestiture 0 1,001
Deferred income taxes (2,658) 593
Other 3,971 703
Changes in certain assets and liabilities:    
Accounts receivable (16,427) (17,757)
Inventories (17,271) (99,486)
Accounts payable and accrued liabilities (46,253) (11,416)
Accrued income taxes 1,524 14,733
Accrued pension and postretirement benefits (6,994) (20,318)
Other 7,212 6,301
Net cash flow (used in) provided by operating activities 126,182 93,023
INVESTING ACTIVITIES    
Purchases of property, plant and equipment (71,083) (60,151)
Disposals of property, plant and equipment 4,774 765
Proceeds from divestiture (Note 3) 0 1,001
Other 95 62
Net cash flow used in investing activities (66,214) (58,323)
FINANCING ACTIVITIES    
Net increase (decrease) in notes payable (567) (7,111)
Net increase revolving and other lines of credit 43,600 27,500
Purchase of capital stock (37,556) (50,522)
The effect of employee benefit and stock plans and dividend reinvestment (6,036) (6,889)
Cash dividends paid to Shareholders (48,468) (50,062)
Other (986) (682)
Net cash flow provided by (used in) financing activities (50,013) (87,766)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (2,067) (999)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 7,888 (54,065)
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents $ 93,474 $ 99,982